ATE342918T1 - Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma - Google Patents

Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma

Info

Publication number
ATE342918T1
ATE342918T1 AT99913538T AT99913538T ATE342918T1 AT E342918 T1 ATE342918 T1 AT E342918T1 AT 99913538 T AT99913538 T AT 99913538T AT 99913538 T AT99913538 T AT 99913538T AT E342918 T1 ATE342918 T1 AT E342918T1
Authority
AT
Austria
Prior art keywords
asthma
diagnosis
flap
genomic sequence
lipoxygenase
Prior art date
Application number
AT99913538T
Other languages
English (en)
Inventor
Marta Blumenfeld
Ilya Chumakov
Lydie Bougueleret
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27374096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE342918(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE342918T1 publication Critical patent/ATE342918T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AT99913538T 1998-04-15 1999-04-15 Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma ATE342918T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8189398P 1998-04-15 1998-04-15
US9131498P 1998-06-30 1998-06-30
US12340699P 1999-03-08 1999-03-08

Publications (1)

Publication Number Publication Date
ATE342918T1 true ATE342918T1 (de) 2006-11-15

Family

ID=27374096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913538T ATE342918T1 (de) 1998-04-15 1999-04-15 Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma

Country Status (11)

Country Link
US (4) US6531279B1 (de)
EP (1) EP1071710B2 (de)
JP (1) JP4472173B2 (de)
AT (1) ATE342918T1 (de)
AU (1) AU768721B2 (de)
CA (1) CA2321226C (de)
DE (1) DE69933661T3 (de)
DK (1) DK1071710T4 (de)
ES (1) ES2272061T5 (de)
PT (1) PT1071710E (de)
WO (1) WO1999052942A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531279B1 (en) * 1998-04-15 2003-03-11 Genset S.A. Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma
US6537751B1 (en) * 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
US6986987B1 (en) * 1998-07-24 2006-01-17 The Uab Research Foundation Genetic polymorphism in the receptor for IgA
EP1218536A2 (de) 1999-02-12 2002-07-03 Genset Biallele marker abgeleitet von genomischen regionen, die gene enthalten, die am arachidonsäure stoffwechsel beteiligt sind
AU780412B2 (en) * 1999-11-30 2005-03-17 Asahi Breweries, Ltd. Method of judging flocculating properties of bottom brewer's yeast
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US7205146B1 (en) * 2000-06-14 2007-04-17 Oscient Pharmaceuticals Corporation Nucleotide and amino acid sequences relating to respiratory diseases and obesity
CN1329012A (zh) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 一种新的多肽——烟酰胺腺嘌呤脱氧二核苷酸依赖性白三烯b412－羟基脱氢酶36和编码这种多肽的多核甘酸
EP1354061A2 (de) * 2000-09-08 2003-10-22 Iowa State University Research Foundation, Inc. Neue prkag3 allele und verwendungen derselben als genetische marker für reproduktivität- und fleisch-qualitätsmerkmale
AU2002224229B2 (en) * 2000-10-31 2007-11-29 Wouter Herman Robert Coppieters Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene DGAT1
EP1352970B1 (de) * 2000-12-12 2010-06-02 Nagoya Industrial Science Research Institute Verfahren zur abschätzung des risikos der expression einer durch die verabreichung einer verbindung, die entweder per se durch ugt1a1 metabolisiert wird oder deren zwischenverbindung durch das enzym metabolisiert wird, hervorgerufenen unerwünschten arzneimittelwirkung
FI114483B (fi) * 2001-02-20 2004-10-29 Jurilab Ltd Oy Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US7115726B2 (en) * 2001-03-30 2006-10-03 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
AU785425B2 (en) 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
ATE335851T1 (de) * 2001-04-19 2006-09-15 Hubit Genomix Inc Verfahren zur abschätzung des diplotyps aus dem genotyp eines individuums
WO2003029422A2 (en) * 2001-10-01 2003-04-10 Mount Sinai School Of Medicine Noonan syndrome gene
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
NZ535140A (en) * 2002-03-04 2008-08-29 Texas A & M Univ Sys Genetic markers linked to the bovine somatostatin (SST) locus, single nucleotide polymorphisms (SNPs) in the bovine SST locus, all of which are predictive of a particular trait of interest, such as marbling, meat quality grade, and yield grade
US7579147B2 (en) * 2002-05-07 2009-08-25 Wake Forest University Health Sciences Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
AU2003243151A1 (en) * 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
ATE397098T1 (de) * 2002-08-30 2008-06-15 Oncotherapy Science Inc Verfahren zur diagnostik von eierstock endometriose
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
WO2005027886A2 (en) * 2003-09-17 2005-03-31 Decode Genetics Ehf. Methods of preventing or treating recurrence of myocardial infarction
CA2502359A1 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction
US7507531B2 (en) * 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
CA2502357A1 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction; methods of treatment
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits
US7803538B2 (en) * 2003-06-20 2010-09-28 Aventis Pharma Sa Method for detecting Alzheimer's disease
WO2005012294A1 (en) * 2003-07-30 2005-02-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
US7335474B2 (en) 2003-09-12 2008-02-26 Perlegen Sciences, Inc. Methods and systems for identifying predisposition to the placebo effect
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
JP2007315752A (ja) * 2004-08-16 2007-12-06 Ajinomoto Co Inc 肝線維化ステージの判定方法
WO2007053844A2 (en) * 2005-10-31 2007-05-10 Rigel Pharmaceuticals, Inc. Compositions and methods for treating inflammatory disorders
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US20080082583A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US10546652B2 (en) 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US8122073B2 (en) * 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
US7853626B2 (en) 2006-09-29 2010-12-14 The Invention Science Fund I, Llc Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
US20110129826A1 (en) * 2007-10-29 2011-06-02 Riken Method for determination of inflammatory disease by using single nucleotide polymorphism in brca1-related protein (brap) gene
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US8568980B2 (en) 2009-01-27 2013-10-29 Mount Sinai School Of Medicine Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
EP2576834A4 (de) * 2010-05-26 2013-11-20 Philadelphia Children Hospital Zusammensetzungen und verfahren zur diagnose und behandlung des primären insulin-wachstumsfaktor-mangels und von idiopathischem kleinwuchs
MX347954B (es) 2010-09-29 2017-05-19 Agensys Inc Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
EP2865756A1 (de) 2013-10-22 2015-04-29 Sylentis, S.A.U. siRNA und deren Verwendung in Verfahren und Zusammensetzungen zur Hemmung der Expression des FLAP-Gens
US10080748B2 (en) 2014-02-04 2018-09-25 Bioscience Pharma Partners, Llc Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system
KR102713301B1 (ko) 2015-12-11 2024-10-02 고쿠리츠다이가쿠호진 고치다이가쿠 췌장암 및 췌장관 내 유두상 점액성 종양의 마커
JP7623281B2 (ja) * 2018-11-15 2025-01-28 パーソナル ゲノム ダイアグノスティクス インコーポレイテッド 免疫療法で治療されたがん患者の応答の予測を改善する方法
AU2019392090A1 (en) 2018-12-03 2021-06-17 Agensys, Inc. Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
KR102527520B1 (ko) * 2020-09-16 2023-05-03 순천대학교 산학협력단 직업성 천식 진단용 조성물 및 이를 이용한 직업성 천식 진단방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032253C (en) 1989-12-15 2000-11-28 John W. Gillard 5-lipoxygenase activating protein
US5182367A (en) * 1990-11-30 1993-01-26 Merck & Co., Inc. 5-lipoxygenase activating protein
US5578443A (en) * 1991-03-06 1996-11-26 Regents Of The University Of Minnesota DNA sequence-based HLA typing method
WO1995003335A1 (en) * 1993-07-26 1995-02-02 K.O. Technology, Inc. Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
US5696076A (en) * 1994-06-22 1997-12-09 Human Genome Sciences, Inc. 5-lipoxygenase-activating protein II
CA2253823A1 (en) 1996-05-06 1997-11-13 Brigham And Women's Hospital 5-lipoxygenase gene polymorphisms and their use in classifying patients
US6531279B1 (en) * 1998-04-15 2003-03-11 Genset S.A. Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma

Also Published As

Publication number Publication date
US7118869B2 (en) 2006-10-10
JP4472173B2 (ja) 2010-06-02
US7494777B2 (en) 2009-02-24
EP1071710B1 (de) 2006-10-18
EP1071710A2 (de) 2001-01-31
AU3164499A (en) 1999-11-01
CA2321226C (en) 2011-06-07
US20070003971A1 (en) 2007-01-04
DK1071710T4 (da) 2011-12-12
ES2272061T3 (es) 2007-04-16
US20050196752A1 (en) 2005-09-08
DK1071710T3 (da) 2007-02-19
PT1071710E (pt) 2007-01-31
DE69933661T2 (de) 2007-08-23
AU768721B2 (en) 2004-01-08
ES2272061T5 (es) 2012-02-24
WO1999052942A2 (en) 1999-10-21
US6531279B1 (en) 2003-03-11
US7838241B2 (en) 2010-11-23
DE69933661T3 (de) 2012-01-26
WO1999052942A3 (en) 2000-02-03
JP2002511242A (ja) 2002-04-16
CA2321226A1 (en) 1999-10-21
EP1071710B2 (de) 2011-11-02
US20090155806A1 (en) 2009-06-18
DE69933661D1 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
ATE342918T1 (de) Genomische sequenz des 5-lipoxygenase- aktivierenden proteins (flap), polymorphische marker und ihre anwendung in der diagnose von asthma
WO2002059604A3 (en) Diagnosis and treatment of multiple sclerosis
EP1521083A3 (de) Verfahren zur Diagnose und zur Charakterisierung von Schlaganfall
WO1999049807A3 (en) A device and method for performing a biological modification of a fluid
WO2004060278A3 (en) Methods for rapid identification of pathogens in humans and animals
WO2003048300A3 (en) Methods of identifying cellular target molecules
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
WO2002098355A3 (en) Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
DE60032784D1 (de) Markerproteine für prostatakrebs
ATE392620T1 (de) Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen
ATE342510T1 (de) Komplementierungsassay für den nachweis von protein-löslichkeit und -faltung
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
WO2001062785A3 (en) Protein and gene and their use for diagnosis and treatment of schizophrenia
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
WO2004039312A3 (en) Optineurin and glaucoma
WO2001069261A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
EP1572931A4 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
WO2001063295A3 (en) Dpi-6, a therapeutic biomarker in neurological disorders
WO2001083524A3 (en) Rna metabolism proteins
WO2003001212A3 (en) A method for diagnosing a person having multiple sclerosis
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
WO2000023466A3 (en) Human rna binding proteins
WO1999016899A3 (en) Molecular diagnostic of glaucomas associated with chromosomes 2 and 6

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1071710

Country of ref document: EP

EEFA Change of the company name